Vince Martin

Vince Martin

InvestorPlace Contributor

Vince Martin has written investing advice for several years, covering stocks across a range of industries. A former registered representative, Martin saw the dot-com bubble inflate and burst in real time, creating a healthy respect for downside risk. He splits his time between Chicago and rural Wisconsin with his wife and three dogs.

Recent Articles

Why Groupon Inc (GRPN) Stock Is Far Too Scary to Be a Good Bargain

By Vince Martin, InvestorPlace Contributor

Groupon (GRPN) earnings knocked the stock down 13%. But that doesn't mean Groupon stock presents a buying opportunity.

3 Reasons Advanced Micro Devices, Inc. (AMD) Stock Will Rebound

By Vince Martin, InvestorPlace Contributor

AMD stock was punished after Q1 earnings. But the long-term story for Advanced Micro Devices still holds. New chips and better margins are on the way.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Bounce Now

By Vince Martin, InvestorPlace Contributor

Teva Pharmaceutical's first-quarter earnings and reaffirmed guidance are good enough, and should at least drive a relief rally in TEVA stock.

Nvidia Corporation (NVDA) Stock Finally Erupts With Stellar Q1

By Vince Martin, InvestorPlace Contributor

NVDA stock finally was rocked out of its slumber by a monster Q1 and stellar Q2 guidance that negates much of the bear case against Nvidia.

Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Still Hot Garbage

By Vince Martin, InvestorPlace Contributor

Valeant Pharmaceuticals flipped to a profit in Q1, and VRX stock is jumping by double digits. But Valeant's long-term issues haven't budged.

Load More